ADAM10 and Alzheimer disease: ADAM10 as a therapeutic target in AD is thought to be beneficial for disease treatment as it initiates the non-amyloidogenic pathway and could prevent the downstream effects of AD (Endres and Fahrenholz, 2010; Lichtenthaler, 2011; Marcello et al., 2017; Lichtenthaler et al., 2022).